Castle Biosciences, Inc. (CSTL)
21.34
+1.65
(+8.38%)
USD |
NASDAQ |
May 27, 10:47
Castle Biosciences Shareholders Equity (Quarterly) : 461.42M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | 7.366B |
| Labcorp Holdings, Inc. | 8.729B |
| Psychemedics Corp. | -- |
| Fulgent Genetics, Inc. | 1.050B |
| Guardant Health, Inc. | -181.07M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 547.80M |
| Total Liabilities (Quarterly) | 86.39M |
| Debt to Equity Ratio | 0.0796 |
| Current Ratio | 6.745 |
| Net Debt Paydown Yield | -0.28% |